JASCAYD Trademark

Trademark Overview


On Wednesday, June 21, 2023, a trademark application was filed for JASCAYD with the United States Patent and Trademark Office. The USPTO has given the JASCAYD trademark a serial number of 79376569. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, September 26, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The JASCAYD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevent...
jascayd

General Information


Serial Number79376569
Word MarkJASCAYD
Filing DateWednesday, June 21, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 17, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, August 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 29, 2024ASSIGNED TO EXAMINER
Saturday, March 2, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 22, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 29, 2023APPLICATION FILING RECEIPT MAILED
Friday, March 1, 2024NON-FINAL ACTION WRITTEN
Friday, March 22, 2024REFUSAL PROCESSED BY MPU
Tuesday, April 16, 2024REFUSAL PROCESSED BY IB
Friday, September 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER